Scientists have identified a hidden barrier that prevents immunotherapy from working against a rare liver cancer. Immunotherapy, which activates the body’s own immune system to kill cancer cells, has transformed treatment for some cancers, but it has largely fallen short against a rare, aggressive liver tumor called fibrolamellar carcinoma. A Cornell University team now reports […]
Source link